Xerostomia Research Today is a free monthly online journal that collates and summarizes the latest research about Xerostomia, including details on dry mouth, treatment, causes, lack of saliva.

Volume 1 (2005), Issue 5 (July)

1. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria.
   Autoimmun Rev, 4(5): 276-81. [Abstract] [Full-text]
2. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
   Arthritis Rheum, 52(7): 2109-19. [Abstract] [Full-text]
3. Autoimmunity and coxsackievirus infection in primary Sjogren's syndrome.
   Ann N Y Acad Sci, 1050: 389-96. [Abstract] [Full-text]
4. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
   Ann N Y Acad Sci, 1050: 210-6. [Abstract] [Full-text]
5. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
   Jpn J Clin Oncol, 35(7): 375-9. [Abstract] [Full-text]
6. Pulmonary hypertension in primary Sjögren's syndrome: report of a case and review of the literature.
   Clin Rheumatol, 24(4): 431-4. [Abstract] [Full-text]
7. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
   Rheumatology (Oxford), 44(8): 1021-5. [Abstract] [Full-text]
8. Sjögren's syndrome.
   Lancet, 366(9482): 321-31. [Abstract] [Full-text]
9. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.
   Genes Immun, 6(5): 457-8. [Abstract] [Full-text]
10. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Arthritis Rheum, 52(6): 1773-84. [Abstract] [Full-text]

© 2005-2008 Xerostomia Research Today. All Rights Reserved.